Clinical Trials Browser

Phase 2 × INDUSTRY × navitoclax × Clear all

NCT01087151 2016-11-02

A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01423539 2016-11-02

NAVIGATE

Phase 2 Withdrawn

Lymphoma, Large B-Cell, Diffuse